Skip to main content
Erschienen in: Pituitary 6/2016

08.09.2016

Childhood acromegaly due to X-linked acrogigantism: long term follow-up

verfasst von: Rebecca J. Gordon, Jennifer Bell, Wendy K. Chung, Raphael David, Sharon E. Oberfield, Sharon L. Wardlaw

Erschienen in: Pituitary | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Acromegaly in infancy is extremely rare. We describe a 32 year old woman who presented at 6 months of age with isolated macrocephaly, followed by accelerated linear growth. At 21 months of age, her head circumference was 55 cm (+5.5 SD), height was 97.6 cm (+4.4 SD) and weight was 20.6 kg (+6.2 SD). She had markedly elevated levels of growth hormone (GH) (135 ng/ml), IGF-1 (1540 ng/ml) and prolactin (370 ng/ml). A pituitary macroadenoma was surgically resected. Immunohistochemical staining was positive for GH. Post-operatively, she developed ACTH and TSH deficiency and diabetes insipidus.

Methods

Long term clinical follow-up and genetic testing with chromosomal microarray analysis.

Results

Despite GH deficiency, she grew well until 7 ½ years old, with subsequent decline in growth velocity, and received GH therapy for 5 years. Puberty was initiated with estrogen therapy. As an adult, she has no stigmata of acromegaly, with a height of 164.5 cm and non-acromegalic features. IGF-1 has remained in the low normal range. Prolactin has been mildly elevated. Serial MRIs have shown no evidence of tumor recurrence. She receives replacement therapy with hydrocortisone, levothyroxine and DDAVP. Chromosomal microarray analysis revealed that she has X-linked acrogigantism (X-LAG) due to a de novo duplication of Xq26.3 (516 kb). She recently became pregnant following ovarian stimulation and chorionic villus sampling revealed that she is carrying a male with the same duplication.

Conclusion

This report provides detailed long term clinical follow-up of a patient with X-LAG syndrome.
Literatur
1.
Zurück zum Zitat Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq A-L et al (2015) Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22:745–757CrossRefPubMed Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq A-L et al (2015) Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22:745–757CrossRefPubMed
2.
Zurück zum Zitat Blumberg DL, Sklar CA, David R, Rothenberg S, Bell J (1989) Acromegaly in an Infant. Pediatrics 83:998–1002PubMed Blumberg DL, Sklar CA, David R, Rothenberg S, Bell J (1989) Acromegaly in an Infant. Pediatrics 83:998–1002PubMed
3.
Zurück zum Zitat Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO et al (2014) Gigantism and Acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371:2363–2374CrossRefPubMedPubMedCentral Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO et al (2014) Gigantism and Acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371:2363–2374CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Naves LA, Daly AF, Dias LA, Yuan B, Zakir JCO, Barra GB, et al. (2015) Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. Endocrine 2015 Nov (Epub, ahead of print) Naves LA, Daly AF, Dias LA, Yuan B, Zakir JCO, Barra GB, et al. (2015) Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. Endocrine 2015 Nov (Epub, ahead of print)
5.
Zurück zum Zitat Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR et al (2015) X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 22:353–367CrossRefPubMedPubMedCentral Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR et al (2015) X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 22:353–367CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Rostomyan L, Daly AF, Beckers A (2015) Pituitary gigantism: causes and clinical characteristics. Ann Endocrinol (Paris) 76:643–649CrossRef Rostomyan L, Daly AF, Beckers A (2015) Pituitary gigantism: causes and clinical characteristics. Ann Endocrinol (Paris) 76:643–649CrossRef
7.
Zurück zum Zitat Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH et al (2016) GHRH excess and blockade in X-LAG syndrome. Endocr Relat Cancer 23(3):161–170CrossRefPubMed Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH et al (2016) GHRH excess and blockade in X-LAG syndrome. Endocr Relat Cancer 23(3):161–170CrossRefPubMed
8.
Zurück zum Zitat Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L et al (2016) Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer 23(4):221–233CrossRefPubMed Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L et al (2016) Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer 23(4):221–233CrossRefPubMed
Metadaten
Titel
Childhood acromegaly due to X-linked acrogigantism: long term follow-up
verfasst von
Rebecca J. Gordon
Jennifer Bell
Wendy K. Chung
Raphael David
Sharon E. Oberfield
Sharon L. Wardlaw
Publikationsdatum
08.09.2016
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 6/2016
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-016-0743-0

Weitere Artikel der Ausgabe 6/2016

Pituitary 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.